Multiple sclerosis (MS) is an inflammatory disease of the central nervous s
ystem. The primary pathological target in multiple sclerosis is myelin. Mos
t MS patients follow a relapsing-remitting (RR-MS) course for 10 to 15 year
s that transforms into a chronic or secondary progressive disease (SP-MS).
This review summarizes studies from our laboratory that implicate activated
microglia and astrocytes in early stages of myelin destruction in MS brain
. In addition, we review evidence that indicates that axonal transection is
a major pathological process in multiple sclerosis. Our data support the h
ypothesis that neurological disability in RR-MS is due to inflammatory demy
elination while axonal loss plays a significant role in the irreversible ne
urological decline in SP-MS. Further elucidation of the pathological target
s and pathological mechanisms of tissue destruction in MS brain will help i
dentify new therapeutics. (C) 1999 Elsevier Science B.V. All rights reserve
d.